Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | BMC Cancer

Fig. 2

From: Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population

Fig. 2

Expression of CCL27 in nasopharyngeal epithelial tissue from a NPC patient and a VCA-IgA–positive healthy donor. a–h Representative images showing immunohistochemical staining of CCL27 in NPC tumor tissue (low CCL27 expression: a-b, high CCL27 expression:c-d) and VCA-IgA–positive healthy tissue (low CCL27 expression: e-f, high CCL27 expression: g-h). Scale bars: a and c = 100 μm; b and d = 50 μm

Back to article page